Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

Clinical trial NCT06671236 · RECRUITING

Trial details

NCT number: NCT06671236
Sponsor: Novabio Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2024-11-21
Primary completion: 2026-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.